A 65-year-old woman with recurrent breast cancer was repeatedly treated with bevacizumab, an anti-VEGF antibody. In addition, she was also frequently prescribed a nonsteroidal anti-inflammatory drug for abdominal pain. Melena was revealed 2 months after the final treatment with bevacizumab, and an endoscopic study revealed a duodenal ulcer (DU) that was resistant to anti-ulcer therapy. A cholangiography identified a biliary-duodenal fistula with bile juice leaking from the ulcer base. Therefore, a biliary stent was placed into the common bile duct for 3 months until the DU healed. This is the first case of a refractory DU with a biliary-duodenal fistula in a patient treated with bevacizumab.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.11405/nisshoshi.113.1244 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Intraluminal endoscopy for biliary duodenal obstruction].
Khirurgiia (Mosk)
February 2023
Sklifosovsky Research Institute for Emergency Care, Moscow, Russian Federation.
Cholelithiasis complicated by cholecystoduodenal fistula and small bowel biliary obstruction is an absolute indication for surgical treatment. Modern possibilities of intraluminal endoscopy (electrohydraulic lithotripsy) made it possible to avoid intra-abdominal access (laparotomy, laparoscopy) and postoperative complications. Finally, rapid rehabilitation was noted.
View Article and Find Full Text PDFSpontaneous postoperative choledochoduodenal fistula due to bile duct injury following laparoscopic cholecystectomy.
Int J Surg Case Rep
August 2016
Afyon Kocatepe University, The Faculty of Medicine, General Surgery Department, 03020, Afyon, Turkey.
Introduction: Bile leak after cholecystectomy which is the frequency less than 2% is an important problem for patients. Some bile duct injuries occuring after laparoscopic cholecystectomy are the complex bile duct injuries and can cause bile leak and fistula.
Presentation Of Case: A 74-year-old woman has high output bile drainage from abdominal drain after laparoscopic cholecystectomy so an ERCP was performed.
[A refractory duodenal ulcer with a biliary-duodenal fistula following the administration of bevacizumab].
Nihon Shokakibyo Gakkai Zasshi
July 2016
Department of Gastroenterology, Gihoku Kosei Hospital.
A 65-year-old woman with recurrent breast cancer was repeatedly treated with bevacizumab, an anti-VEGF antibody. In addition, she was also frequently prescribed a nonsteroidal anti-inflammatory drug for abdominal pain. Melena was revealed 2 months after the final treatment with bevacizumab, and an endoscopic study revealed a duodenal ulcer (DU) that was resistant to anti-ulcer therapy.
View Article and Find Full Text PDFA hinged metalloplastic anastomotic device: a novel method for choledochoduodenostomy.
Gastrointest Endosc
June 2009
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8019, USA.
Background: In biliary obstruction, the creation of a large-diameter permanent fistula between the bile duct and the duodenum would be attractive.
Objective: To invent, prototype, and test a new method of forming a biliary duodenal anastomosis.
Design: Survival and nonsurvival porcine model.
[Biliary-duodenal fistula following radiofrequency ablation therapy for hepatocellular carcinoma].
Korean J Gastroenterol
March 2008
Department of Internal Medicine, Inje University College of Medicine, Busan, Korea.
Hepatocellular carcinoma (HCC) is one of the most common malignant neoplasms occurring worldwide. Surgical resection currently provides the best chance of long-term tumor free survival, but the most HCCs are not candidates for surgical excision due to poor liver function or poor medical background. Numerous noninvasive alternatives to surgical resection have been introduced to treat liver cancers.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!